Back to search results

Kentucky LEADS Collaborative Lung Cancer Survivorship Care Intervention

This study is testing two approaches for lung cancer survivors: the Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program (KLCLCSC) and Enhanced Usual Care (EUC). KLCLCSC is a program designed to help lung cancer survivors and their caregivers with emotional and behavioral support. EUC combines standard care with educational materials and assessments. The study aims to see if these programs improve your quality of life after lung cancer. You may be able to join if you have been diagnosed with lung cancer, live in a rural county, are at least 18 years old, and can communicate in English. The study is looking to enroll 300 participants, but its current status is unclear.

Study design
This is a randomized study comparing two groups of participants. It plans to enroll 300 lung cancer survivors.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your lung cancer quality of life will be measured at the beginning of the study and again after 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05857995

Precision Lung Cancer Survivorship Care Intervention

Recruiting
NAAges 18+InterventionalSupportive care
Jerod L Stapleton, PhD
~300 participants
Updated 2026-02-23 on ClinicalTrials.gov
What's tested:Kentucky LEADS Collaborative Lung Cancer Survivorship Care ProgramEnhanced Usual Care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change from Baseline (T0) in Mean Lung Cancer Quality of Life at 6 Months (T2)
Measured over Baseline (T0) and 6 Months (T2)

Conditions

Lung Cancer
Pulmonary Neoplasm
Neoplasms, Lung
Neoplasms, Pulmonary
Neoplasm, Pulmonary
Cancer, Lung
Cancers, Lung
Pulmonary Cancer
Cancer, Pulmonary
Cancers, Pulmonary
Pulmonary Cancers
Cancer of the Lung
Cancer of Lung
Pulmonary Neoplasms
Lung Cancers

Explore related trials

Lung Carcinoma

Where it's being run

1 sites across 1 states
Kentucky1

Study leadership

  • Jamie L Studts, PhD · PRINCIPAL_INVESTIGATOR · University of Colorado School of Medicine
  • Jerod L Stapleton, PhD · PRINCIPAL_INVESTIGATOR · University of Kentucky

Who to contact

Jerod L Stapleton, PhD
[email protected]
8593237224
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Have been diagnosed with lung cancer
Reside in a rural county as determined by a Rural Urban Continuum Code (RUC) of 4 or higher
Be at least 18 years of age or older
Be able to communicate effectively in English

Exclusion

Have significant psychiatric disturbance that requires a higher level of care
Have substance abuse/dependence that requires a higher level of care
Are participating in another lung cancer survivorship care intervention
Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program

What this trial measures

  • Change from Baseline (T0) in Mean Lung Cancer Quality of Life at 6 Months (T2)Baseline (T0) and 6 Months (T2)

    The Functional Assessment of Cancer Therapy-Lung (FACT-L) is a 36-item self-report instrument that measures quality life. Scores range from 0 to 144 with higher scores indicating better quality of life.